Paul Roepman
7PUBLICATIONS
66CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 01, 2025
Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol.Karlijn Verkerk, Soemeya F Haj Mohammad, Laurien J Zeverijn
|Oct 01, 2024
Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery Protocol.Karlijn Verkerk, Tijmen J W T van der Wel, Laurien J Zeverijn
|Jul 18, 2024
The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol.Laurien J Zeverijn, Birgit S Geurts, Thomas W Battaglia
|May 15, 2024
Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.Birgit S Geurts, Laurien J Zeverijn, Jade M van Berge Henegouwen
|Apr 17, 2024
Efficacy of Pembrolizumab and Biomarker Analysis in Patients with WGS-Based Intermediate to High Tumor Mutational Load: Results from the Drug Rediscovery Protocol.Birgit S Geurts, Laurien J Zeverijn, Lindsay V M Leek
|Dec 18, 2023
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.Ilse A C Spiekman, Birgit S Geurts, Laurien J Zeverijn
Pageof 2
Frequent Collaborators
6 joint publications
Anne Ml Jansen
6 joint publications
Emile E Voest
6 joint publications
Hans Gelderblom
5 joint publications
Henk Mw Verheul
5 joint publications
Laurien J Zeverijn
5 joint publications
Wendy Wj de Leng
5 joint publications
Birgit S Geurts
5 joint publications
Vincent van der Noort
4 joint publications
Ilse Ac Spiekman
3 joint publications
Jade M van Berge Henegouwen
